Descemet's Membrane Endothelial Keratoplasty Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids

Ophthalmology

Volumn 123, Issue 6, 2016, Pages 1232-1236

  Price, Marianne O ^a   Scanameo, Amanda ^a   Feng, Matthew T ^b   Price, Francis W ^b  

^a Lautert)   (United States)

^b PRICE VISION GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROMETHOLONE; LOTEPREDNOL ETABONATE; PREDNISOLONE ACETATE; EYE DROPS; GLUCOCORTICOID; PREDNISOLONE;

ADULT; AGED; ARTICLE; CONGENITAL CORNEA DYSTROPHY; CONTROLLED STUDY; CORNEA TRANSPLANTATION; CORNEAL ENDOTHELIAL CELL LOSS; DENSITY; DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY; ENDOTHELIUM CELL; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; ANALOGS AND DERIVATIVES; CELL COUNT; CORNEA ENDOTHELIUM; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; DRUG EFFECTS; FUCHS' ENDOTHELIAL DYSTROPHY; GRAFT SURVIVAL; IMMUNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; TOPICAL DRUG ADMINISTRATION; TREATMENT WITHDRAWAL; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; CORNEAL ENDOTHELIAL CELL LOSS; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; ENDOTHELIUM, CORNEAL; FEMALE; FLUOROMETHOLONE; FUCHS' ENDOTHELIAL DYSTROPHY; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LONGITUDINAL STUDIES; LOTEPREDNOL ETABONATE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PREDNISOLONE; PROSPECTIVE STUDIES; RISK FACTORS; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 84960425544     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.02.001     Document Type: Article

References (17)

1. S. Klebe, D.J. Coster, and K.A. Williams Rejection and acceptance of corneal allografts Curr Opin Organ Transplant 14 2009 4 9
2. M.O. Price, R.W. Thompson Jr., and F.W. Price Jr. Risk factors for various causes of failure in initial corneal grafts Arch Ophthalmol 121 2003 1087 1092
3. M.G. Maguire, W.J. Stark, J.D. Gottsch, and et al. Risk factors for corneal graft failure and rejection in the Collaborative Corneal Transplantation Studies. Collaborative Corneal Transplantation Studies Research Group Ophthalmology 101 1994 1536 1547
4. F.W. Price, D.A. Price, V. Ngakeng, and M.O. Price Survey of steroid usage patterns during and after low-risk penetrating keratoplasty Cornea 28 2009 865 870
5. A. Anshu, M.O. Price, and F.W. Price Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty Ophthalmology 119 2012 536 540
6. I. Dapena, L. Ham, M. Netukova, and et al. Incidence of early allograft rejection after Descemet membrane endothelial keratoplasty Cornea 30 2011 1341 1345
7. M.O. Price, M.T. Feng, A. Scanameo, and F.W. Price Jr. Loteprednol etabonate 0.5% gel vs. prednisolone acetate 1% solution after Descemet membrane endothelial keratoplasty: prospective randomized trial Cornea 34 2015 853 858
8. M.O. Price, F.W. Price Jr., F.E. Kruse, and et al. Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after Descemet membrane endothelial keratoplasty Cornea 33 2014 880 886
9. C.S. Jordan, M.O. Price, R. Trespalacios, and F.W. Price Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part one: clinical signs and symptoms Br J Ophthalmol 93 2009 387 390
10. A.J. Epstein, T.N. de Castro, P.R. Laibson, and et al. Risk factors for the first episode of corneal graft rejection in keratoconus Cornea 25 2006 1005 1011
11. J.Y. Li, M.A. Terry, J. Goshe, and et al. Graft rejection after Descemet's stripping automated endothelial keratoplasty Ophthalmology 119 2012 90 94
12. T.S. Vajaranant, M.O. Price, F.W. Price, and et al. Visual acuity and intraocular pressure after Descemet's stripping endothelial keratoplasty in eyes with and without preexisting glaucoma Ophthalmology 116 2009 1644 1650
13. C. Baudouin, H. Liang, P. Hamard, and et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways Ophthalmology 115 2007 109 115
14. J. Shimazaki, A. Iseda, Y. Satake, and S. Shimazaki-Den Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty Ophthalmology 119 2012 668 673
15. N.X. Nguyen, B. Seitz, A.L. Martus, and C. Cursiefen Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty Am J Ophthalmol 144 2007 318 319
16. J.C. Tsai A comprehensive perspective on patient adherence to topical glaucoma therapy Ophthalmology 116 2009 S30 S36
17. M.O. Price, C.S. Jordan, G. Moore, and F.W. Price Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors Br J Ophthalmol 93 2009 391 395